Compare BGC & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGC | NOVT |
|---|---|---|
| Founded | 1945 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 1999 | 1999 |
| Metric | BGC | NOVT |
|---|---|---|
| Price | $10.93 | $125.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $144.00 |
| AVG Volume (30 Days) | ★ 2.1M | 310.7K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | ★ 24.00 | N/A |
| EPS | 0.31 | ★ 1.47 |
| Revenue | ★ $2,941,460,000.00 | $521,290,000.00 |
| Revenue This Year | $21.02 | $8.71 |
| Revenue Next Year | $7.86 | $6.47 |
| P/E Ratio | ★ $35.23 | $85.14 |
| Revenue Growth | 29.99 | ★ 35.49 |
| 52 Week Low | $8.12 | $98.27 |
| 52 Week High | $11.15 | $149.95 |
| Indicator | BGC | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 72.10 | 54.44 |
| Support Level | $8.64 | $111.73 |
| Resistance Level | N/A | $129.50 |
| Average True Range (ATR) | 0.31 | 4.64 |
| MACD | 0.15 | 1.55 |
| Stochastic Oscillator | 86.74 | 92.69 |
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, the Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.